Clinical Trials on COVID-19, SARS CoV 2 Infection

Total 8151 results

Centre Hospitalier Universitaire de Nice

Completed

Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients (PredictCovid-D)

COVID-19 by SARS-CoV-2 Infection

France
Shanghai Henlius Biotech
Huashan Hospital; Shanghai Fosun Pharmaceutical Industrial Development Co.... and other collaborators

Recruiting

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Ousehold in China

COVID-19

China
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

COVID-19 | SARS-CoV-2 Infection
Consorci Sanitari de Terrassa
Institut Català de la Salut

Recruiting

Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection

COVID-19

Spain
DHR Health Institute for Research and Development

Recruiting

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

COVID-19 | SARS CoV 2 Infection

United States
Cancer Institute and Hospital, Chinese Academy...
Hubei Provincial Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

SARS-CoV-2 Infection

China
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

SARS-CoV-2 Infection

China
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
University of Valladolid
Instituto de Salud Carlos III; Sanidad de Castilla y León

Recruiting

Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2

SARS-CoV-2 Infection

Spain
Centre Hospitalier Universitaire de Besancon

Recruiting

Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) (COV-CREM)

SARS-CoV-2 Infection

France
Health Institutes of Turkey

Completed

Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent

COVID-19 | Sars-CoV-2 Infection

Turkey
University of Calgary
Health Canada

Completed

PERC Health Canada COVID-19

COVID-19 | SARS-CoV-2 Infection

Canada
Université Catholique de Louvain
University of Liege; Université Libre de Bruxelles

Active, not recruiting

SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonia - Brussels: An Epidemiological Pilot Study (DYNAtracs)

SARS-CoV-2 Infection

Belgium
Maria Goossens
Institute of Tropical Medicine; Erasme University Hospital; Université Libre... and other collaborators

Active, not recruiting

Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations (COVICO)

COVID-19 | SARS CoV 2 Infection

Belgium
WestVac Biopharma Co., Ltd.
West China Hospital

Completed

A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

COVID-19 | SARS-CoV-2 Infection

China
BioNTech SE
Pfizer

Completed

A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States
Shionogi
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)

SARS-CoV-2 Infection

United States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
Instituto de Investigación Hospital Universitario...

Completed

Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19

SARS-CoV-2 Infection

Spain
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...

Completed

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

SARS-CoV-2 Infection

Mexico
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Agencia Mexicana de Cooperación...

Completed

Study of a Live rNDV Based Vaccine Against COVID-19

SARS-CoV-2 Infection

Mexico
MP Biomedicals, LLC
EDP Biotech

Completed

COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability

COVID-19 | Sars-CoV-2 Infection

United States
Beijing Ditan Hospital

Completed

A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19

COVID-19 | SARS-CoV-2 Infection

China
BioNTech SE
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Great Ormond Street Hospital for Children NHS Foundation...

Completed

COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) (Co-Stars)

SARS-CoV-2 Infection

United Kingdom
Bassett Healthcare
Goshen Health System; Reid Health

Terminated

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 (COVIDMED)

SARS-CoV-2 Infection

United States
Shaare Zedek Medical Center
Ministry of Health, Israel

Unknown

COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity

SARS-CoV-2 Infection

Israel
Klinikum Bayreuth GmbH

Unknown

Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects

SARS-CoV-2 Infection

Germany
Huoshenshan Hospital
Ascletis Pharmaceuticals Co., Ltd.

Completed

Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

COVID-19

China
Assistance Publique - Hôpitaux de Paris

Unknown

COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells (MEMO-COV2)

COVID-19 | SARS-CoV-2 Infection
The Ninth Hospital of Nanchang
Ascletis Pharmaceuticals Co., Ltd.

Completed

Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

COVID-19

China
University of Chicago

Recruiting

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection (COVID-19)

COVID-19

United States
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection
Direction Centrale du Service de Santé des Armées

Recruiting

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics (COVOICE)

COVID-19 | Sars-CoV-2 Infection

France
Bioxytran Inc.

Not yet recruiting

To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M

COVID-19 | SARS CoV 2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

COVID-19 | SARS-CoV-2 Infection
Centre Hospitalier Régional d'Orléans

Recruiting

Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies (PNAS)

COVID-19 | SARS CoV 2 Infection

France
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
WestVac Biopharma Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster

COVID-19 | SARS-CoV-2 Infection

Mexico
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19 | SARS CoV 2 Infection

Australia
Atea Pharmaceuticals, Inc.

Active, not recruiting

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

COVID-19 | SARS CoV 2 Infection

United States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection

China
University of Cologne
Boehringer Ingelheim; ZKS Köln

Completed

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

SARS-CoV-2 Infection

Germany
BioNTech SE
Pfizer

Active, not recruiting

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States
Health Institutes of Turkey

Completed

Phase 3 Booster Vaccination Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Speransa Therapeutics

Terminated

A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins

SARS-CoV-2 Infection

United States, Germany
Serap Yavuz
MDX Klinik Araştırma Egitim ve Danismanlik Ltd. Sti.

Active, not recruiting

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

COVID-19 | SARS-CoV-2 Infection

Turkey
Pfizer

Completed

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

SARS-CoV-2 Infection

United States

Clinical Trials on COVID-19, SARS CoV 2 Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations